Cite
HARVARD Citation
Wirth, S. et al. (2018). Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study. Hepatology. 68 (5), pp. 1681-1694. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wirth, S. et al. (2018). Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study. Hepatology. 68 (5), pp. 1681-1694. [Online].